CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-11 | Bolzon Bradley J PhD Director | Sale | −1,100 | $128.65 | $142K | 21,130 |
| 2021-06-11 | Bolzon Bradley J PhD Director | Sale | −755 | $129.45 | $98K | 20,375 |
| 2021-06-10 | Behbahani Ali Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-10 | Treco Douglas A Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-10 | High Katherine A Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-10 | Greene John Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-10 | George Simeon Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-10 | Bolzon Bradley J PhD Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-10 | Fleming Harold Edward Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-06-01 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −779 | $115.80 | $90K | 187,719 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise | +12,000 | $44.67 | $536K | 25,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise | +22,000 | $51.49 | $1.1M | 47,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise | +10,000 | $29.87 | $299K | 57,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise | +20,000 | $40.87 | $817K | 77,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise | +12,000 | $14.43 | $173K | 89,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise | +12,000 | $17.66 | $212K | 101,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Sale | −88,000 | $128.20 | $11.3M | 13,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Sale | −12,000 | $126.97 | $1.5M | 1,050 |
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise · Stock Option (Right to Buy) | −12,000 | 2,666 | ||
| 2021-03-23 | Klein Lawrence Otto CBO & COO | Option exercise · Stock Option (Right to Buy) | −12,000 | 3,000 |
Page 29 of 46 · 910 trades